Skip to content

Clinical trials

Glomerulonephritis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20202
20213
20221
20232
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Active, not recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Alexion Pharmaceuticals, Inc.1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Astellas Pharma Korea, Inc.1
HI-Bio, A Biogen Company1
Human Genome Sciences Inc., a GSK Company1
Jade Biosciences, Inc.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Swedish Orphan Biovitrum1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis15
Glomerulonephritis, IGA10
Kidney Diseases9
Renal Insufficiency, Chronic6
Urologic Diseases6
Autoimmune Diseases4
Nephritis4
Immune System Diseases3
Lupus Nephritis2
Proteinuria2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.